Richard J. Berman - Nov 9, 2023 Form 4 Insider Report for BIOVIE INC. (BIVI)

Role
Director
Signature
/S/ RICHARD J BERMAN
Stock symbol
BIVI
Transactions as of
Nov 9, 2023
Transactions value $
$0
Form type
4
Date filed
12/6/2023, 04:15 PM
Previous filing
Aug 24, 2023
Next filing
Jan 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIVI Common Stock Award $0 +51.8K +297.79% $0.00 69.2K Nov 9, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting.
F2 On August 22, 2023, the reporting person filed a Form 4 which inadvertently reported that, following his exercise of an option and sale of the underlying stock, he directly owned 16,789 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person directly owned 17,405 shares of common stock.